Detalles de la búsqueda
1.
Impact of the 21-Gene Recurrence Score Assay on Treatment Decisions and Cost in Patients with Node-Positive Breast Cancer: A Multicenter Study in Quebec.
Oncologist
; 27(10): 822-831, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35830543
2.
Behavioral and health outcomes from the NRG Oncology/NSABP B-36 trial comparing two different adjuvant therapy regimens for early-stage node-negative breast cancer.
Breast Cancer Res Treat
; 192(1): 153-161, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35112166
3.
Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
Breast Cancer Res Treat
; 193(3): 555-564, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35230585
4.
Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer.
Breast Cancer Res
; 22(1): 9, 2020 Jan 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31969184
5.
Wage losses among spouses of women with nonmetastatic breast cancer.
Cancer
; 126(5): 1124-1134, 2020 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31821547
6.
NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer.
Breast Cancer Res
; 21(1): 133, 2019 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31796073
7.
Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combination.
Breast Cancer Res Treat
; 178(2): 389-399, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31428908
8.
Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study.
Ann Surg Oncol
; 26(13): 4337-4345, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31605348
9.
Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
Breast Cancer Res Treat
; 193(3): 565, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35507135
10.
The identification of challenges in tissue collection for biomarker studies: the Q-CROC-03 neoadjuvant breast cancer translational trial experience.
Mod Pathol
; 30(11): 1567-1576, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28752846
11.
Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial.
Ann Surg Oncol
; 24(2): 398-406, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27663567
12.
The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40.
Ann Surg Oncol
; 24(7): 1853-1860, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27864694
13.
Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial.
J Surg Oncol
; 115(8): 917-923, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28407247
14.
Comparative Evaluation of Iodine-125 Radioactive Seed Localization and Wire Localization for Resection of Breast Lesions.
Can Assoc Radiol J
; 68(4): 447-455, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28927740
15.
Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial.
Lancet Oncol
; 16(9): 1037-1048, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26272770
16.
Bevacizumab added to neoadjuvant chemotherapy for breast cancer.
N Engl J Med
; 366(4): 310-20, 2012 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-22276821
17.
Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9.
Breast Cancer Res Treat
; 152(2): 399-405, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26126970
18.
The Added Value of Statistical Modeling of Backscatter Properties in the Management of Breast Lesions at US.
Radiology
; 275(3): 666-74, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25496215
19.
Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial.
Lancet Oncol
; 15(2): 156-63, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24439313
20.
Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study.
Breast Cancer Res Treat
; 146(1): 153-62, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24924416